DDW covers some of the biggest announcements from the second day of SLAS2026.  

 

Emulate showcases organ-chip platform at SLAS2026

 

Emulate has brought its AVA Emulation System to SLAS2026, showcasing the potential to accelerate drug development with a first-of-its-kind high-throughput organ-chip platform.

Read more…

 

Charles River and Synthace to advance assay development

Charles River Laboratories has announced a collaboration with software and assay developer Synthace to advance assay development in drug discovery.

Read more…

 

QIAGEN presents new sample processing system at SLAS2026


The QIAsprint Connect marks the company’s entry into high-throughput sample processing, enabling preparation of up to 192 samples per run while reducing plastic consumption.

Read more…

 

Omega Bio-tek presents automation-friendly workflow

Manufacturer Omega Bio-tek has presented a new workflow offering a high-throughput, automation-friendly platform at SLAS2026.

Read more…

 

Promega launches cellular target engagement platform


Promega has launched a new live-cell target engagement platform aiming to close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins.

Read more…

 

Cenevo launches AI agents to accelerate lab operations


Cenevo has advanced towards agentic labs with the launch of two new AI agents.

Read more…

 

UniteLabs presents AI-ready lab automation system

The Operating System replaces vendor-specific instruments and software with an open, Python-based infrastructure, giving lab automation engineers and scientists full control and transparency over their workflows.

Read more…